Our Next Show: Shutting Down Myeloma Progression in Smoldering Myeloma with Dr. Ajay Nooka, MD, MPH, FACP
Listen Live via Computer Can multiple myeloma be cured by shutting it down early before it turns from smoldering to active myeloma? Dr. Ajay Nooka, MD of the Emory Winship Cancer Institute joins us to talk about new, early-stage clinical trials being explored for smoldering myeloma patients including a new OncoPep vaccine to prevent progression. Our discussion will consider the "beginning of the end of myeloma." Dr. Ajay Kumar Nooka, MD, MPH, FACP, is an Assistant Professor of Hematology and Medical Oncology at Emory University School of Medicine and a part of the hematology care team at Winship Cancer Institute of Emory University. His research interests include integrating genomic and clinical data on a uniform platform and to interpret in a meaningful way to risk-stratify myeloma; and evaluate newer myeloma therapeutic strategies aimed at prolonging survival in myeloma patients. Dr. Nooka serves on the editorial board for The American Journal of Clinical Oncology, Journal of Hematological Malignancies, Lymphoma and Chronic Lymphocytic Leukemias. He is an ad-hoc Journal Reviewer for Annals of Oncology, Cancer, Oncology, Leukemia Research, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, European Journal of Cancer, Current-Oncology, Indian Journal of Medical Research and International Journal of Hematology. Dr. Nooka has received awards from the MMRF, the IMF, the Conquer Foundation ASCO Merit Award, the Fellowship of American College of Physicians, the AACR/ASCO Methods in Clinical Cancer Research Workshop, the Frederick C. Whittier Excellence in Research Award and additional recognition for his research efforts.